Skip to main content
Top
Published in: Annals of Hematology 10/2022

03-08-2022 | Mantle Cell Lymphoma | Original Article

Prognostic value and computer image analysis of p53 in mantle cell lymphoma

Authors: Yue-Hua Zhang, Li-Min Gao, Xiao-Yu Xiang, Wen-Yan Zhang, Wei-Ping Liu

Published in: Annals of Hematology | Issue 10/2022

Login to get access

Abstract

P53 prognostic cut-off values differ between studies of mantle cell lymphoma (MCL), and its immunohistochemistry (IHC) interpretation is still based on semiquantitative estimation, which might be inaccurate. This study aimed to investigate the optimal cut-off value for p53 in predicting prognosis of patients with MCL and the possible use of computer image analysis to identify the positive rate of p53. We calculated p53 positive rate using QuPath software and compared it with the data obtained by manual counting and semiquantitative estimation. Survival curves were generated by using the Youden index and the Kaplan–Meier method. The chi-squared (χ2) test was used to compare MIPI, Ann Arbor stage, and cell morphology with p53. Spearman rank correlation test and Bland–Altman analysis were used to compare manual counting, computer image analysis and semiquantitative estimation, as well as the consistency between different observers. The optimal cut-off value of p53 for predicting prognosis was 20% in MCL patients. Patients with p53 ≥ 20% had a significantly worse overall survival (OS) than those with p53 < 20% (P < 0.0001). MCL patients with MIPI intermediate to high risk, Ann Arbor stage III–IV, and blastoid/pleomorphic variant cell morphology had more p53 ≥ 20%. There was a strong correlation between computer image analysis and manual counting of p53 from the same areas in MCL tissues (Spearman’s rho = 0.966, P < 0.0001). The results of computer analysis are completely consistent between observers, and computer image analysis of Ki-67 can predict the prognosis of MCL patients. MCL patients with p53 ≥ 20% had a shorter OS and a tendency for MIPI intermediate to high risk, Ann Arbor stage III–IV, and blastoid/pleomorphic variant. Computer image analysis could determine the actual positive rate of p53 and Ki-67 and is a more attractive alternative than semiquantitative estimation in MCL.

Graphical abstract

Appendix
Available only for authorised users
Literature
2.
go back to reference Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, Szymczyk M, Bouabdallah R, Kneba M, Hallek M, Salles G, Feugier P, Ribrag V, Birkmann J, Forstpointner R, Haioun C, Hänel M, Casasnovas RO, Finke J, Peter N, Bouabdallah K, Sebban C, Fischer T, Dührsen U, Metzner B, Maschmeyer G, Kanz L, Schmidt C, Delarue R, Brousse N, Klapper W, Macintyre E, Delfau-Larue MH, Pott C, Hiddemann W, Unterhalt M, Dreyling M (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet (London, England) 388(10044):565–575. https://doi.org/10.1016/s0140-6736(16)00739-xCrossRef Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, Szymczyk M, Bouabdallah R, Kneba M, Hallek M, Salles G, Feugier P, Ribrag V, Birkmann J, Forstpointner R, Haioun C, Hänel M, Casasnovas RO, Finke J, Peter N, Bouabdallah K, Sebban C, Fischer T, Dührsen U, Metzner B, Maschmeyer G, Kanz L, Schmidt C, Delarue R, Brousse N, Klapper W, Macintyre E, Delfau-Larue MH, Pott C, Hiddemann W, Unterhalt M, Dreyling M (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet (London, England) 388(10044):565–575. https://​doi.​org/​10.​1016/​s0140-6736(16)00739-xCrossRef
3.
go back to reference X-q LI, G-d LI, Z-f GAO, X-g ZHOU, X-z ZHU (2012) Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10002 cases. Journal of Diagnostics Concepts & Practice 11(02):111–115 X-q LI, G-d LI, Z-f GAO, X-g ZHOU, X-z ZHU (2012) Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10002 cases. Journal of Diagnostics Concepts & Practice 11(02):111–115
4.
go back to reference Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558–565. https://doi.org/10.1182/blood-2007-06-095331CrossRefPubMed Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558–565. https://​doi.​org/​10.​1182/​blood-2007-06-095331CrossRefPubMed
5.
go back to reference Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, Barth TF, Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W (2016) Prognostic value of Ki-67 Index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(12):1386–1394. https://doi.org/10.1200/jco.2015.63.8387CrossRef Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, Barth TF, Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W (2016) Prognostic value of Ki-67 Index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(12):1386–1394. https://​doi.​org/​10.​1200/​jco.​2015.​63.​8387CrossRef
6.
go back to reference Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 28 (suppl_4):iv62-iv71. https://doi.org/10.1093/annonc/mdx223 Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 28 (suppl_4):iv62-iv71. https://​doi.​org/​10.​1093/​annonc/​mdx223
10.
go back to reference Aukema SM, Hoster E, Rosenwald A, Canoni D, Delfau-Larue MH, Rymkiewicz G, Thorns C, Hartmann S, Kluin-Nelemans H, Hermine O, Dreyling M, Klapper W (2018) Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood 131(4):417–420. https://doi.org/10.1182/blood-2017-07-797019CrossRefPubMed Aukema SM, Hoster E, Rosenwald A, Canoni D, Delfau-Larue MH, Rymkiewicz G, Thorns C, Hartmann S, Kluin-Nelemans H, Hermine O, Dreyling M, Klapper W (2018) Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood 131(4):417–420. https://​doi.​org/​10.​1182/​blood-2017-07-797019CrossRefPubMed
11.
go back to reference Nordström L, Sernbo S, Eden P, Grønbaek K, Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundström C, Laurell A, Delabie J, Ehinger M, Jerkeman M, Ek S (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma–a Nordic Lymphoma Group study. Br J Haematol 166(1):98–108. https://doi.org/10.1111/bjh.12854CrossRefPubMedPubMedCentral Nordström L, Sernbo S, Eden P, Grønbaek K, Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundström C, Laurell A, Delabie J, Ehinger M, Jerkeman M, Ek S (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma–a Nordic Lymphoma Group study. Br J Haematol 166(1):98–108. https://​doi.​org/​10.​1111/​bjh.​12854CrossRefPubMedPubMedCentral
12.
go back to reference Choe JY, Yun JY, Na HY, Huh J, Shin SJ, Kim HJ, Paik JH, Kim YA, Nam SJ, Jeon YK, Park G, Kim JE (2016) MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma. Histopathology 68(3):442–449. https://doi.org/10.1111/his.12760CrossRefPubMed Choe JY, Yun JY, Na HY, Huh J, Shin SJ, Kim HJ, Paik JH, Kim YA, Nam SJ, Jeon YK, Park G, Kim JE (2016) MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma. Histopathology 68(3):442–449. https://​doi.​org/​10.​1111/​his.​12760CrossRefPubMed
13.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA (2017) WHO classification of tumors of haematopoietic and lymphoid tissues. Revised 4th Edition. IARC press, Lyon, France Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA (2017) WHO classification of tumors of haematopoietic and lymphoid tissues. Revised 4th Edition. IARC press, Lyon, France
14.
16.
go back to reference Paulik R, Micsik T, Kiszler G, Kaszál P, Székely J, Paulik N, Várhalmi E, Prémusz V, Krenács T, Molnár B (2017) An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology. Cytometry Part A : the journal of the International Society for Analytical Cytology 91(6):595–608. https://doi.org/10.1002/cyto.a.23124CrossRef Paulik R, Micsik T, Kiszler G, Kaszál P, Székely J, Paulik N, Várhalmi E, Prémusz V, Krenács T, Molnár B (2017) An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology. Cytometry Part A : the journal of the International Society for Analytical Cytology 91(6):595–608. https://​doi.​org/​10.​1002/​cyto.​a.​23124CrossRef
17.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRef
19.
go back to reference Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London, England) 1(8476):307–310CrossRef Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London, England) 1(8476):307–310CrossRef
20.
go back to reference Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H (2021) NCCN Guidelines® insights: b-cell lymphomas, Version 5.2021. Journal of the National Comprehensive Cancer Network : JNCCN 19 (11):1218–1230. https://doi.org/10.6004/jnccn.2021.0054 Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H (2021) NCCN Guidelines® insights: b-cell lymphomas, Version 5.2021. Journal of the National Comprehensive Cancer Network : JNCCN 19 (11):1218–1230. https://​doi.​org/​10.​6004/​jnccn.​2021.​0054
22.
go back to reference Abrisqueta P, Scott DW, Slack GW, Steidl C, Mottok A, Gascoyne RD, Connors JM, Sehn LH, Savage KJ, Gerrie AS, Villa D (2017) Observation as the initial management strategy in patients with mantle cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology 28(10):2489–2495. https://doi.org/10.1093/annonc/mdx333CrossRef Abrisqueta P, Scott DW, Slack GW, Steidl C, Mottok A, Gascoyne RD, Connors JM, Sehn LH, Savage KJ, Gerrie AS, Villa D (2017) Observation as the initial management strategy in patients with mantle cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology 28(10):2489–2495. https://​doi.​org/​10.​1093/​annonc/​mdx333CrossRef
23.
go back to reference Kimura Y, Sato K, Arakawa F, Karube K, Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, Takeuchi M, Nino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Kikuchi M, Ohshima K (2010) Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67. Cancer Sci 101(3):806–814. https://doi.org/10.1111/j.1349-7006.2009.01433.xCrossRefPubMed Kimura Y, Sato K, Arakawa F, Karube K, Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, Takeuchi M, Nino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Kikuchi M, Ohshima K (2010) Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67. Cancer Sci 101(3):806–814. https://​doi.​org/​10.​1111/​j.​1349-7006.​2009.​01433.​xCrossRefPubMed
Metadata
Title
Prognostic value and computer image analysis of p53 in mantle cell lymphoma
Authors
Yue-Hua Zhang
Li-Min Gao
Xiao-Yu Xiang
Wen-Yan Zhang
Wei-Ping Liu
Publication date
03-08-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-022-04922-8

Other articles of this Issue 10/2022

Annals of Hematology 10/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.